MXPA04001547A - Proteina de leptina porcina, antisentido y anticuerpo. - Google Patents

Proteina de leptina porcina, antisentido y anticuerpo.

Info

Publication number
MXPA04001547A
MXPA04001547A MXPA04001547A MXPA04001547A MXPA04001547A MX PA04001547 A MXPA04001547 A MX PA04001547A MX PA04001547 A MXPA04001547 A MX PA04001547A MX PA04001547 A MXPA04001547 A MX PA04001547A MX PA04001547 A MXPA04001547 A MX PA04001547A
Authority
MX
Mexico
Prior art keywords
porcine
porcine leptin
methods
dna
antibody
Prior art date
Application number
MXPA04001547A
Other languages
English (en)
Inventor
Spurlock Michael
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of MXPA04001547A publication Critical patent/MXPA04001547A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describe un polipeptido de adiposito porcino, moleculas de ADN y ARN que codifican las mismas, metodos para su preparacion, anticuerpos especificos y el polipeptido. Los metodos que limitan la acumulacion de grasa incluyen la administracion adecuada de leptina porcina o ADN de leptina porcina, y los metodos que regulan de ingesta incluyen la administracion de leptina porcina, ADN de leptina porcina, o un anticuerpo dirigido contra leptina porcina.
MXPA04001547A 2001-08-20 2002-08-19 Proteina de leptina porcina, antisentido y anticuerpo. MXPA04001547A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/932,888 US20020127642A1 (en) 1996-07-31 2001-08-20 Porcine leptin protein, antisense and antibody
PCT/US2002/026217 WO2003016489A2 (en) 2001-08-20 2002-08-19 Porcine leptin protein, antisense and antibody

Publications (1)

Publication Number Publication Date
MXPA04001547A true MXPA04001547A (es) 2004-05-17

Family

ID=25463116

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001547A MXPA04001547A (es) 2001-08-20 2002-08-19 Proteina de leptina porcina, antisentido y anticuerpo.

Country Status (6)

Country Link
US (1) US20020127642A1 (es)
EP (1) EP1529059A4 (es)
AU (1) AU2002313767A1 (es)
CA (1) CA2457301A1 (es)
MX (1) MXPA04001547A (es)
WO (1) WO2003016489A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7320868B2 (en) * 2004-03-19 2008-01-22 Arieh Gertler Leptin binding domain compositions and methods thereto
CN100360674C (zh) * 2005-03-30 2008-01-09 中国科学院沈阳应用生态研究所 一种原核表达载体pASK-75-EX
US20110016539A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of neurotransmission-related genes in animals
US20110023141A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved with parkinson's disease
US20110030072A1 (en) * 2008-12-04 2011-02-03 Sigma-Aldrich Co. Genome editing of immunodeficiency genes in animals
US20110023139A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in cardiovascular disease
US20110016540A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
US20110016541A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genome editing of sensory-related genes in animals
US20110023154A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Silkworm genome editing with zinc finger nucleases
US20110023146A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in secretase-associated disorders
US20110023152A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of cognition related genes in animals
US20110023144A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
US20110023151A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of abc transporters
US20110023143A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of neurodevelopmental genes in animals
US20110023148A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of addiction-related genes in animals
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
US20110023147A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of prion disorder-related genes in animals
US20110023149A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in tumor suppression in animals
US20110023150A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genome editing of genes associated with schizophrenia in animals
US20110023156A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Feline genome editing with zinc finger nucleases
US20110016546A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Porcine genome editing with zinc finger nucleases
US20110023153A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in alzheimer's disease
US20110023145A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Genomic editing of genes involved in autism spectrum disorders
US20110023158A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Bovine genome editing with zinc finger nucleases
US20110023140A1 (en) * 2008-12-04 2011-01-27 Sigma-Aldrich Co. Rabbit genome editing with zinc finger nucleases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277592B1 (en) * 1996-07-31 2001-08-21 Purina Mills, Inc. Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof

Also Published As

Publication number Publication date
WO2003016489A8 (en) 2005-03-17
CA2457301A1 (en) 2003-02-27
US20020127642A1 (en) 2002-09-12
EP1529059A4 (en) 2006-01-11
EP1529059A2 (en) 2005-05-11
AU2002313767A1 (en) 2003-03-03
WO2003016489A2 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
MXPA04001547A (es) Proteina de leptina porcina, antisentido y anticuerpo.
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
HK1049501A1 (en) Functional genomics using zinc finger proteins
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2004041865A3 (en) Stabilized single domain antibodies
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
EP1137658A4 (en) TECHNIQUES FOR MODULATING THE EXPRESSION OF CELL ADHESION MOLECULES INDUCED BY TUMOR NECROSIS FACTOR- $ g (a)
WO2004033631A8 (en) Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
GEP20094629B (en) Nogo receptor binding protein
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
WO2001068708A3 (en) Human and humanized fap-alpha-specific antibodies
TW200510450A (en) Soluble fragments of the SARS-CoV spike glycoprotein
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
WO2004019893A3 (en) Modulators of angiogenesis
AU5301196A (en) Method for stimulating an immune response
MY141459A (en) Recombinant anti-idiotypic antibodies
AU2002341090A1 (en) Use of a protein of the crmp family for treating diseases related to the immune system
AU4876196A (en) A process for the preparation of factor ix from biological sources
AU2003247537A1 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
WO2001012806A3 (fr) 'odorant-binding' proteines humaines fixant des ligands hydrophobes: polypeptides et polynucleotides codant lesdits polypeptides et leurs applications
AU2347501A (en) Trp-protein-related mtr1 protein and dna sequence coding therefor
WO2003016473A3 (en) Bovine leptin protein, antisense and antibody
AU3802897A (en) Porcine leptin protein, nucleic acid sequences coding therefor and uses hereof
WO2004053052A3 (en) HUMAN RECOMBINANT ENDOOLIGOPEPTIDASE A (hEOPA)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal